OrthoPediatrics (KIDS) vs Pacific Biosciences of California (PACB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Pacific Biosciences of California (PACB) has outperformed OrthoPediatrics (KIDS) over the past year, gaining 52.3% versus a gain of 20.6%. Over five years, KIDS leads with a -65.6% price change compared with -90.4% for PACB. Pacific Biosciences of California is the larger company by market cap ($724.2 million vs $565.3 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KIDS | PACB |
|---|---|---|
| Share price | $21.65 | $2.33 |
| Market cap | $565.28M | $724.24M |
| 1-day change | -0.51% | +1.30% |
| YTD return | +21.90% | +24.60% |
| 1-year return | +20.61% | +52.29% |
| 5-year return | -65.60% | -90.45% |
| EPS (TTM) | $-1.68 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $26.74 | $3.44 |
| 52-week low | $14.42 | $1.07 |
| Distance from 52-week high | -19.04% | -32.27% |
| Analyst consensus | none | buy |
| Avg. price target upside | +25.73% | +3.00% |
| Average volume | 210.60K | 10.48M |
| Shares outstanding | 26.11M | 310.83M |
| Employees | 602 | 485 |
| Sector | Health Care | Industrials |
| Industry | Medical/Dental Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PACB has outperformed KIDS by 31.7 percentage points over the past year.
- The two companies sit in different sectors: OrthoPediatrics in Health Care and Pacific Biosciences of California in Industrials.
About OrthoPediatrics
KIDS stock →OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products.
Health Care · Medical/Dental Instruments · 602 employees
About Pacific Biosciences of California
PACB stock →Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems.
Industrials · Biotechnology: Laboratory Analytical Instruments · 485 employees
KIDS vs PACB FAQ
Which is bigger, OrthoPediatrics or Pacific Biosciences of California?
Pacific Biosciences of California (PACB) is larger, with a market capitalization of $724.24M compared with $565.28M for OrthoPediatrics (KIDS).
Which stock has performed better over the past year, KIDS or PACB?
PACB returned +52.29% over the past 12 months, compared with +20.61% for KIDS (price return, excluding dividends). Past performance does not predict future results.
Are OrthoPediatrics and Pacific Biosciences of California in the same industry?
No. OrthoPediatrics is in the Health Care sector, while Pacific Biosciences of California is in Industrials.